Steve Lenier

Steve Lenier

Contributing Writer

Steve Lenier began a career in medical literature over 30 years ago. He has worked on a variety of publications and projects, and across a number of specialties. Since 2005 most of his time has been spent covering ophthalmology, both print and online.

  • All
  • Deals
  • Devices and Diagnostics
  • Digital
  • Genetics
  • Pharma

October 14 2020

Ocular Therapeutix Makes Lots of Buzz. Wall Street Notices

Reporting positive top-line clinical trial results, initiating two other clinical trials, getting wider Medicare coverage of its lead product, resolving a regulatory warning letter, and ...
Read More

August 26 2020

Underserved Dry Eye Populations Offer Opportunity for Developing Technologies

The population of US dry eye patients is greatly underserved, but innovative treatments in development are poised to provide more treatment options and capture at ...
Read More

August 12 2020

Bausch Health Spin-Off of Eye Care Business Follows a Familiar Playbook

As Bausch Health pursues a spin-off of its eye health business into an independent company, it’s following a playbook that’s scored well in ophthalmology, and ...
Read More
OIS Virtual Public Company Showcase Panel

July 22 2020

‘A Very Interesting Time’ and Other Insights from OIS Virtual Public Company Showcase

In this time of virtual meetings, the Ophthalmology Innovation Summit (OIS) continues to deliver information and foster innovation. Last week’s OIS Virtual Public Company Showcase ...
Read More
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

July 9 2020

AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

Weeks after completing its acquisition of Allergan, AbbVie is seeking a meeting with the US Food and Drug Administration to talk about the next steps ...
Read More
Necessity Is the Mother of Collaborative Care between Optometrists and Ophthalmologists

June 17 2020

Necessity Is the Mother of Collaborative Care between Optometrists and Ophthalmologists

Collaborative care models – optometrists and ophthalmologists working together on patient care – are emerging as a way to reduce some of the strain caused ...
Read More
AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

May 20 2020

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

Now that it has closed on its $63 billion acquisition of Allergan, AbbVie has significantly expanded its revenue base, which could help cushion the blow ...
Read More
Eyenuk’s EyeArt AI System Showing Its Value

May 13 2020

Eyenuk’s EyeArt AI System Showing Its Value

Eyenuk Inc.’s first product, the EyeArt AI eye screening system, is an artificial intelligence (AI) technology for autonomous detection of diabetic retinopathy that’s been tested ...
Read More
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

April 29 2020

With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

Developing a delivery system to replace eye drops has been an important unmet need in ophthalmology. Drops are difficult or impossible for some patients to ...
Read More
Adverum, Gene Therapy, and AMD

March 25 2020

Adverum, Gene Therapy, and AMD

Adverum, a company pioneering novel gene therapies for ocular diseases, believes a gene therapy treatment for wet age-related macular degeneration (AMD) can reduce treatment burden ...
Read More
Innovations a Highlight at Dry Eye Breakout Session

January 8 2020

Innovations a Highlight at Dry Eye Breakout Session

The dry eye disease (DED) market is expected to have an annual compound growth rate of 4.5% between 2017 and 2025, which should help it ...
Read More
BioGenware’s Speculet Seeks to Improve the Patient Experience

December 18 2019

BioGenware’s Speculet Seeks to Improve the Patient Experience

For those undergoing intravitreal injections (and there are about 22 million of these performed yearly worldwide), a common complaint is that the speculum is uncomfortable, ...
Read More